Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,173 | 5,192 | 5,596 | 6,744 | 14,134 |
| Receivables | 21,463 | 17,091 | 19,921 | 21,420 | 20,883 |
| Inventories | 25,087 | 16,848 | 19,955 | 22,343 | 20,531 |
| Income taxes - deferred | N/A | N/A | N/A | 42 | 1,515 |
| Other current assets | 3,109 | 8,404 | 0 | 0 | 0 |
| TOTAL | $57,832 | $47,535 | $45,472 | $50,549 | $57,063 |
| Non-Current Assets | |||||
| PPE Net | 5,898 | 3,743 | 4,296 | 5,902 | 5,190 |
| Intangibles | 103,068 | 47,610 | 18,680 | 62,452 | 62,227 |
| Other Non-Current Assets | 1,815 | 10,466 | 39,317 | 1,147 | 11,436 |
| TOTAL | $110,781 | $61,819 | $62,293 | $69,501 | $78,853 |
| Total Assets | $168,613 | $109,354 | $107,765 | $120,050 | $135,916 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,982 | 2,765 | 2,372 | 2,364 | 5,000 |
| Accounts payable and accrued liabilities | 7,359 | 4,410 | 6,196 | 8,782 | 6,294 |
| Accrued Expenses | 978 | 4,211 | 4,773 | 4,311 | 5,006 |
| Other current liabilities | 7,350 | 2,150 | 760 | 868 | 1,023 |
| TOTAL | $25,489 | $14,041 | $14,601 | $19,323 | $18,099 |
| Non-Current Liabilities | |||||
| Long Term Debt | 54,813 | 8,983 | 11,374 | 16,369 | 16,450 |
| Deferred Revenues | 3,820 | 505 | 500 | 752 | 655 |
| Other Non-Current Liabilities | 3,286 | 2,777 | 3,177 | 2,985 | 4,574 |
| TOTAL | $60,400 | $14,413 | $20,968 | $23,129 | $22,349 |
| Total Liabilities | $85,889 | $28,454 | $35,569 | $42,452 | $40,448 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,668 | 35,595 | 34,583 | 34,042 | 33,165 |
| Common Shares | 436 | 419 | 418 | 416 | 397 |
| Retained earnings | -119,889 | -116,967 | -116,030 | -111,723 | -92,684 |
| Other shareholders' equity | -13,200 | -10,344 | -16,326 | -11,552 | -7,901 |
| TOTAL | $82,724 | $80,900 | $72,196 | $77,598 | $95,468 |
| Total Liabilities And Equity | $168,613 | $109,354 | $107,765 | $120,050 | $135,916 |